Sarmento Fernando, Tanaka Hideaki, Cordeiro Eduarda, Suzuki Kiyoshi
Altern Ther Health Med. 2017 Dec;23(7):20-26. Epub 2017 Oct 2.
Context • Fibromyalgia (FM) is a disorder with an unknown etiology; symptoms include physical and psychological stress, widespread chronic pain, insomnia, and depression. Mind-body medicine and aerobic exercise have shown positive effects for symptom control. Several studies have reported positive effects for biofield therapy for FM, but when other studies have compared the treatment with a sham control, they have not found those beneficial effects. Objective • The study intended to examine the effects of a biofield therapy called Okada purifying therapy on patients' FM symptoms. Design • An open-label, self-controlled study was conducted with 2 groups of FM patients. Setting • The study was conducted at an integrative medicine clinic in Portugal. Participants • Twelve patients, aged 25 to 59 y, with symptoms of FM for the 3 mo before the study, participated. Participants agreed not to receive any new treatment other than the intervention throughout the study as a condition for participation. Intervention • Participants received 50 min of biofield therapy 2 ×/wk for 3 mo, either during the first half of the 6-mo study for group A or the second half for group B. The second half of the study was designated as a sham control for group A, and the first half of the study was designated as a sham control for group B. Outcome Measures • Measures included the Beck depression inventory (BDI), the fibromyalgia impact questionnaire (FIQ), the tender point index (TPI), and changes in the dosage of prescribed medication. Results • A significant change was observed for scores in the FIQ (P = .027), BDI (P = .027), and TPI (P = .027) in the second group of patients who received the intervention in the second half of the 6-mo study. Seven of 11 participants taking prescribed medications reduced their dosage. Conclusion • Biofield therapy may help reduce symptoms of depression, chronic widespread pain, and tenderness among patients suffering from FM. Larger studies with rigorous designs are required for further accurate evaluation.
背景 • 纤维肌痛（FM）是一种病因不明的疾病；症状包括身体和心理压力、广泛的慢性疼痛、失眠和抑郁。身心医学和有氧运动已显示出对症状控制有积极作用。几项研究报告了生物场疗法对纤维肌痛的积极作用，但其他一些研究将该疗法与假对照进行比较时，并未发现这些有益效果。目的 • 本研究旨在检验一种名为冈田净化疗法的生物场疗法对纤维肌痛患者症状的影响。设计 • 对两组纤维肌痛患者进行了一项开放标签、自我对照研究。地点 • 该研究在葡萄牙的一家综合医学诊所进行。参与者 • 12名年龄在25至59岁之间、在研究前3个月有纤维肌痛症状的患者参与了研究。参与者同意在整个研究期间除干预措施外不接受任何新的治疗作为参与条件。干预 • 参与者每周接受2次、每次50分钟的生物场疗法，为期3个月，A组在6个月研究的前半段接受，B组在研究的后半段接受。研究的后半段被指定为A组的假对照，研究的前半段被指定为B组的假对照。结局指标 • 测量指标包括贝克抑郁量表（BDI）、纤维肌痛影响问卷（FIQ）、压痛点指数（TPI）以及处方药物剂量的变化。结果 • 在6个月研究后半段接受干预的第二组患者中，FIQ（P = 0.027）、BDI（P = 0.027）和TPI（P = 0.027）得分有显著变化。11名服用处方药物的参与者中有7人减少了剂量。结论 • 生物场疗法可能有助于减轻纤维肌痛患者的抑郁症状、慢性广泛性疼痛和压痛。需要进行更严格设计的更大规模研究以进行进一步准确评估。
